Revolution Medicines Inc
Held by 1 mutual fund scheme, ₹5.31Cr between them.
The largest single position is Motilal Oswal Nasdaq Q50 ETF (Motilal Oswal), which holds 3.3% of its portfolio in Revolution Medicines Inc — ₹5.31Cr, or 100.0% of all the mutual fund money in this stock.
Funds holding Revolution Medicines Inc
1Largest rupee position first. One row per scheme — a fund’s Direct and Regular plans hold the same portfolio, so the Direct plan stands for both.
| Fund | Category | Weight | Position | Fund size |
|---|---|---|---|---|
| Motilal Oswal Nasdaq Q50 ETF | Other ETFs | 3.27% | ₹5.31Cr | ₹162.45Cr |
Weights come from each fund’s most recent disclosed portfolio, which SEBI requires monthly — positions can have changed since. “Position” is the weight applied to the scheme’s AUM. Nothing here is advice, and a stock being widely held is not an argument for owning it.
Frequently asked questions
Which mutual fund holds the most Revolution Medicines Inc?
By rupee value, Motilal Oswal Nasdaq Q50 ETF from Motilal Oswal — ₹5.31Cr, at 3.3% of that scheme's portfolio. Weights come from each fund's most recent disclosed portfolio; SEBI requires monthly disclosure, so a fund that has traded since its last filing may hold more or less than this.
How many mutual funds hold Revolution Medicines Inc?
1 scheme, holding ₹5.31Cr between them across the 1 whose AUM is on record. One row per scheme: a fund's Direct and Regular plans hold the same portfolio, so the Direct plan stands for both rather than counting twice.
Does a fund holding Revolution Medicines Inc make it a good investment?
No. This page reports what funds disclosed they own, not a view on the stock or on any scheme holding it. A widely held stock is a popular one, which is a fact about other people's positions rather than about future returns. Nothing here is investment advice.